Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Broker's call: Emcure Pharma (Buy)
Pune headquartered Emcure Pharmaceuticals is a diversified pharma player focused on developing, manufacturing and marketing a broad range of pharmaceutical products in the domestic/international markets. Emcure's domestic business combines a strong…
Exclusive | Billionaire pharma heir wants $35M for LA mansion as he prepares to build the world's biggest yacht
He's looking to “seas” the day. Billionaire pharmaceutical heir Frank Binder is lifting the anchor on his dazzling Lenny Kravitz-designed Hollywood Hills mansion as he prepares to build the world's largest yacht. Binder listed the…
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Given Consensus Recommendation of 'Moderate Buy' by Analysts
Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report) have received an average recommendation of 'Moderate Buy' from the five analysts that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with…
BlackRock Inc. Acquires New Stake in Nuvectis Pharma, Inc. $NVCT
BlackRock Inc. bought a new position in shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 1,001,285 shares…
HC Wainwright Expects Weaker Earnings for BridgeBio Pharma
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) - Research analysts at HC Wainwright dropped their Q3 2026 earnings per share (EPS) estimates for shares of BridgeBio…
Sapient Capital LLC Takes Position in Ascendis Pharma A/S $ASND
Sapient Capital LLC purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 92,162 shares of…
Nuvectis Pharma (NASDAQ:NVCT) Upgraded by Lucid Cap Mkts to 'Strong-Buy' Rating
Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) was upgraded by investment analysts at Lucid Cap Mkts to a 'strong-buy' rating in a research note issued on Tuesday, Zacks reports. A number of other analysts have also commented on NVCT. Cantor…
Athira Pharma, Inc. (NASDAQ:LONA) Receives Average Recommendation of 'Moderate Buy' from Brokerages
Shares of Athira Pharma, Inc. (NASDAQ:LONA - Get Free Report) have been given a consensus recommendation of 'Moderate Buy' by the six brokerages that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock…
23,950 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by Corient Private Wealth LP
Corient Private Wealth LP purchased a new stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 23,950…
Public Employees Retirement System of Ohio Takes $3.59 Million Position in BridgeBio Pharma, Inc. $BBIO
Public Employees Retirement System of Ohio acquired a new position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 48,191 shares…
A city that keeps reinventing its industrial DNA
Hyderabad's industrial development has been a story of continual reinvention. From the sprawling facilities of public sector enterprises and industrial estates dotted with factories to the rise of pharmaceutical giants, IT parks and, more recently…
102,000 Orion Corporation A shares converted into B shares
STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 102,000 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 102,000…
Inside The Focus Economy
Tyson Gundersen is CEO of Bureau, designing soundproof office booths for workplaces globally. He writes on workplace design and attention. There was a time when silence was so abundant it had no market value. Silence drifted through open windows…
The Self-Driving Pharmaceutical Company
Nagesh Nama, CEO, xLM. Nagesh Nama is a seasoned technology executive with over 30 years of experience in life sciences. Imagine a pharmaceutical plant where no one is chasing a missing signature, hunting for a lost batch record or waiting…
RPG Life Sciences acquiring Raghava Life Sciences' API, intermediates business for ₹135 crore
RPG Life Sciences is acquiring the active pharmaceutical ingredients (API) and intermediates business of Raghava Life Sciences for ₹135 crore. Only business assets are being acquired and not shares of any entity, RPG Life Sciences said…
Receive a Daily briefing on Pharma Industry News
Get Started